Company Search:
Advanced Search
Sponsored Links
Genoway Company Snapshot
Genoway operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genoway with three other companies in this sector in France: Ose Immunotherapeutics SA (2017 sales of 6.68 million Euro [US$8.27 million] ), Inventiva SA (6.52 million Euro [US$8.07 million] ), and Genfit (6.86 million Euro [US$8.49 million] ).

Sales Analysis. During the year ended December of 2017, sales at Genoway were 9.90 million Euro (US$12.25 million). This is an increase of 9.1% versus 2016, when the company's sales were 9.08 million Euro. This was the fifth consecutive year of sales increases at Genoway (and since 2012, sales have increased a total of 34%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Genoway
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.83
(Figures in Euro)
1 Week 3.7%   13 Weeks 7.0%  
4 Weeks -11.4%   52 Weeks -3.9%  
Genoway Key Data:
  Ticker: ALGEN Country: France
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 9,900,000
(Year Ending Jan 2018).
Employees: 92
  Currency: Euro Market Cap: 10,866,995
  Fiscal Yr Ends: December Shares Outstanding: 5,954,518
  Share Type: Action Ordinaries Closely Held Shares: 1,696,154
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.